Cargando…

Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two Studies

Background: Neonates may require higher doses of micafungin than adults to reach the therapeutic effect for increased plasma clearance. Only poor and inconclusive data are available still now to support this hypothesis, especially with regard to central nervous system micafungin concentrations. To a...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Rose, Domenico Umberto, Bersani, Iliana, Ronchetti, Maria Paola, Piersigilli, Fiammetta, Cairoli, Sara, Dotta, Andrea, Desai, Amit, Kovanda, Laura Lynn, Goffredo, Bianca Maria, Auriti, Cinzia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051811/ https://www.ncbi.nlm.nih.gov/pubmed/36986569 http://dx.doi.org/10.3390/ph16030472

Ejemplares similares

Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis
por: De Rose, Domenico Umberto, et al.
Publicado: (2021)

Antifungal Drugs for Invasive Candida Infections (ICI) in Neonates: Future Perspectives
por: Bersani, Iliana, et al.
Publicado: (2019)

Use of Meropenem and Other Antimicrobial Lock Therapy in the Treatment of Catheter-Related Blood Stream Infections in Neonates: A Retrospective Study
por: Piersigilli, Fiammetta, et al.
Publicado: (2022)

Staphylococcal meningitis therapy with linezolid in a young infant: efficacy, CSF levels and side effects
por: Auriti, Cinzia, et al.
Publicado: (2020)

Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far
por: De Rose, Domenico Umberto, et al.
Publicado: (2020)

Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus
por: Auriti, Cinzia, et al.
Publicado: (2021)

Exposure–Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials
por: Kovanda, Laura L., et al.
Publicado: (2018)

Incidence of umbilical vein catheter-associated thrombosis of the portal system: A systematic review and meta-analysis
por: Bersani, Iliana, et al.
Publicado: (2021)

Heart rate variability as possible marker of brain damage in neonates with hypoxic ischemic encephalopathy: a systematic review
por: Bersani, Iliana, et al.
Publicado: (2020)

Use of Early Biomarkers in Neonatal Brain Damage and Sepsis: State of the Art and Future Perspectives
por: Bersani, Iliana, et al.
Publicado: (2015)

Staphylococcal Infections and Neonatal Skin: Data from Literature and Suggestions for the Clinical Management from Four Challenging Patients
por: De Rose, Domenico Umberto, et al.
Publicado: (2023)

Editorial: Perinatal assessment of biomarkers in invasive and non-invasive procedures of biological fluid collection
por: Bersani, Iliana, et al.
Publicado: (2022)

Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age
por: De Rose, Domenico Umberto, et al.
Publicado: (2020)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
por: Wiederhold, Nathan P, et al.
Publicado: (2009)

Pooled analysis of safety for micafungin
por: Cornely, OA, et al.
Publicado: (2008)

The Skin as an Early Expression of Malignancies in the Neonatal Age: A Review of the Literature and a Case Series
por: Mondì, Vito, et al.
Publicado: (2015)

Pharmacokinetics of micafungin in adult patients with invasive candidiasis and candidaemia
por: Kuse, ER, et al.
Publicado: (2008)

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
por: Benjamin, Daniel K., et al.
Publicado: (2018)

The Emerging Role of Presepsin (P-SEP) in the Diagnosis of Sepsis in the Critically Ill Infant: A Literature Review
por: Maddaloni, Chiara, et al.
Publicado: (2021)

Impact of early catheter removal during treatment of invasive candidiasis: analysis from two phase 3 micafungin trials
por: Nucci, M, et al.
Publicado: (2009)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011)

Anidulafungin and Micafungin Concentrations in Cerebrospinal Fluid and in Cerebral Cortex
por: Marx, Jana, et al.
Publicado: (2020)

Juvenile idiopathic arthritis in infants with Harlequin Ichthyosis: two cases report and literature review
por: Auriti, Cinzia, et al.
Publicado: (2020)

Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study
por: van der Geest, Patrick J., et al.
Publicado: (2016)

Mannose-Binding Lectin: Biologic Characteristics and Role in the Susceptibility to Infections and Ischemia-Reperfusion Related Injury in Critically Ill Neonates
por: Auriti, Cinzia, et al.
Publicado: (2017)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature
por: Wilke, MH
Publicado: (2011)

A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
por: Kohno, S., et al.
Publicado: (2012)

Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis
por: Ashizawa, Nobuyuki, et al.
Publicado: (2019)

Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis
por: Grant, Victoria C., et al.
Publicado: (2022)

SARS-CoV-2 Vaccines during Pregnancy and Breastfeeding: A Systematic Review of Maternal and Neonatal Outcomes
por: De Rose, Domenico Umberto, et al.
Publicado: (2022)

Micafungin induced apoptosis in Candida parapsilosis independent of its susceptibility to micafungin
por: Shirazi, Fazal, et al.
Publicado: (2015)

Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study
por: Viscoli, Claudio, et al.
Publicado: (2014)

Successful treatment of pulmonary candidiasis and aspergillosis in patient with refractory Hodgkin lymphoma using micafungin – case study and brief literature review
por: Barańska, Marta, et al.
Publicado: (2017)

Editorial: Congenital and perinatal infections: How to prevent sequelaes in neonates and children
por: De Rose, Domenico Umberto, et al.
Publicado: (2023)

Comparison of three clinical scoring tools for bronchiolitis to predict the need for respiratory support and length of stay in neonates and infants up to three months of age
por: De Rose, Domenico Umberto, et al.
Publicado: (2023)

Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
por: Wasmann, Roeland E., et al.
Publicado: (2017)

Clinical and Neurodevelopmental Characteristics of Enterovirus and Parechovirus Meningitis in Neonates
por: Bucci, Silvia, et al.
Publicado: (2022)

Review of the pharmacology and clinical studies of micafungin
por: Bormann, Alison M, et al.
Publicado: (2009)

Cardiac Safety of High-dose Micafungin
por: Stover, Kayla R., et al.
Publicado: (2017)

Pharmacokinetics of Micafungin in Critically Ill Patients
por: Gastine, Silke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cjillro5enhfi04o6jt1fv46e0